Effects of Clopidogrel with Proton Pump Inhibitors on Cardiovascular Events in Patients with Type 2 Diabetes Mellitus after Bare-Metal Stent

被引：0
|
作者：
Hsieh, Chi-Feng [1 ]
Lu, Pei-Yu [1 ]
Huang, Weng-Foung [1 ]
机构：
[1] Natl Yang Ming Univ, Coll Med, Inst Hlth & Welf Policy, Taipei 112, Taiwan
来源：
DRUG SAFETY | 2012年 / 35卷 / 10期
关键词：
ADVERSE OUTCOMES; CONCOMITANT USE; RISK;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：917 / 918
页数：2
相关论文
共 50 条
  • [31] Comparison of bare metal stent with pioglitazone versus sirolimus-eluting stent for percutaneous coronary intervention in patients with Type 2 diabetes mellitus
    Nishio, Kazuaki
    Shigemitsu, Meiei
    Kodama, Yusuke
    Konno, Noburu
    Katagiri, Takashi
    Kobayashi, Youichi
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2009, 10 (01) : 5 - 11
  • [32] Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel (vol 31, pg 810, 2010)
    Kwok, C. S.
    Loke, Y. K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (05) : 696 - 696
  • [33] Stented length-to-diameter ratio predicts complexity of bare-metal in-stent restenosis after adjustment for effects of diabetes mellitus, clinical and angiographic covariates
    Nathan, S
    Chugh, AR
    Amin, AP
    Al Dallow, R
    Haynie, J
    Almeda, FQ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 44B - 44B
  • [34] Safety of clopidogrel and proton pump inhibitors in patients undergoing drug-eluting stent implantation
    Rossini, Roberta
    Capodanno, Davide
    Musumeci, Giuseppe
    Lettieri, Corrado
    Lortkipanidze, Nikoloz
    Romano, Michele
    Nijaradze, Tamar
    Tarantini, Giuseppe
    Cicorella, Nicola
    Sirbua, Vasile
    Guagliumi, Giulio
    Rosiello, Renato
    Valsecchi, Orazio
    Gavazzi, Antonello
    CORONARY ARTERY DISEASE, 2011, 22 (03) : 199 - 205
  • [35] The Effect of Proton Pump Inhibitors on Glycemic Control in Patients with Type 2 Diabetes
    Villegas, Kelly
    Meier, Joy L.
    Long, Maureen
    Lopez, Julio
    Swislocki, Arthur
    METABOLIC SYNDROME AND RELATED DISORDERS, 2019, 17 (04) : 192 - 196
  • [36] THE EFFECT OF PROTON PUMP INHIBITORS ON GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES
    Villegas, K.
    Meier, J.
    Long, M.
    Lopez, J.
    Swislocki, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (01) : 226 - 226
  • [37] Risk of Adverse Cardiovascular Events with Concomitant Use of Proton Pump Inhibitors and Clopidogrel: A Meta-Analysis
    Shukla, Ashish
    Shukla, Sandhya
    Paris, Joseph A.
    Boden, William E.
    CIRCULATION, 2010, 122 (21)
  • [38] Impact of pioglitazone on cardiovascular events in patients with type-II diabetes mellitus after drug-eluting stent implantation
    Yokoi, H.
    EUROPEAN HEART JOURNAL, 2016, 37 : 2 - 2
  • [39] A Comparison of Aspirin and Clopidogrel With or Without Proton Pump Inhibitors for the Secondary Prevention of Cardiovascular Events in Patients at High Risk for Gastrointestinal Bleeding
    Hsiao, Fei-Yuan
    Tsai, Yi-Wen
    Huang, Weng-Foung
    Wen, Yu-Wen
    Chen, Pei-Fen
    Chang, Po-Yin
    Kuo, Ken N.
    CLINICAL THERAPEUTICS, 2009, 31 (09) : 2038 - 2047
  • [40] Clinical Profile and Outcomes of Patients with Very Late Thrombosis after Bare-Metal Stent Implantation
    Gomez-Blazquez, I
    Fernandez-Barbeira, S.
    Bastos-Fernandez, G.
    de Miguel-Castro, A. A.
    Jimenez-Diaz, V. A.
    Ortiz-Saez, A.
    Baz-Alonso, J. A.
    Iniguez-Romo, A.
    CORONARY ARTERY DISEASE 2013, 2013, : 311 - 313
12345